GlassScriptPhysician profile
Brian T Paquette
NPI 1952370397
$17,526.84
in general payments reported to CMS, 2019-2025
81 companies · $2,233 in 2025
The $2,233 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,594 · 2020: $1,511 · 2021: $2,360 · 2022: $2,506 · 2023: $2,999 · 2024: $3,323 · 2025: $2,233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,150 · Travel and Lodging: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,150.43 |
| Travel and Lodging | $404.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,198.70 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $1,956.37 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Neurocrine Biosciences, INC. | $987.60 | 2019-2025 | Ingrezza |
| Boston Scientific Corporation | $928.43 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, General - Therapies |
| Eisai INC. | $592.14 | 2019-2025 | |
| Lundbeck LLC | $559.55 | 2019-2025 | Vyepti, Rexulti |
| Novartis Pharmaceuticals Corporation | $517.66 | 2019-2025 | |
| Pfizer INC. | $505.77 | 2019-2025 | |
| Si-Bone, INC. | $492.52 | 2024-2025 | |
| Impel Pharmaceuticals INC. | $411.61 | 2022-2023 | Trudhesa |
| Nevro Corp. | $350.52 | 2019 | |
| Arbor Pharmaceuticals, INC. | $333.68 | 2020-2022 | |
| Vertos Medical, INC. | $324.07 | 2019-2023 | Mild Device Kit |
| Amgen INC. | $294.06 | 2019-2025 | Evenity, Prolia, Uplizna |
| Abbott Laboratories | $279.84 | 2019-2021 |
Show all 81 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Paquette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.